| Gleba, Yurijus (Yuri) (Icon Genetics 200501 CEO) |
Chief Executive Officer (CEO) |
Denka (Group) |
Germany |
| Gleeson, Martin (Genalyte 201209 VP Development + Applications) |
n. a. |
Genalyte Inc. |
United States (USA) |
| Glerup, Simon (Draupnir Bio 202106– CSO before CEO + Co-Founder) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Draupnir Bio ApS |
Denmark |
| Glick, Gary D. (Odyssey Therapeutics 202112 CEO + Co-Founder before Scorpion Therapeutics + IFM Therapeutics) |
Chief Executive Officer (CEO) |
Odyssey Therapeutics (US) |
United States (USA) |
| Glieder, Anton (ACIB GmbH 201108 Managing Director) |
Managing Director |
ACIB GmbH – Austrian Centre of Industrial Biotechnology |
Austria |
| Gligor, Mark (Helmholtz 201206 Biotechnologie Strategie BIO1 at Projektträger Jülich at FZ Jülich) |
n. a. |
Helmholtz-Gemeinschaft (HGF) (Group) |
Germany |
| Glinca, Serghei (CrystalsFirst 201709) |
n. a. |
CrystalsFirst GmbH |
Germany |
| Gline, Matt (Roivant 202102 CEO of Roivant Sciences) |
Chief Executive Officer (CEO) |
Roivant (Group) |
United States (USA) |
| Glinka, Jacek (Mylan 201312– President of European Business before Polpharma Group CEO) |
President/Director/Head Business Group/Unit/Division |
Mylan (Group) |
United States (USA) |
| Glombitza, Stefan (Formycon 202207– CEO joined 201610 as COO) |
Chief Executive Officer (CEO) |
Formycon (Group) |
Germany |
| Glund, Konrad (Probiodrug 1997–201804 Founder + CEO 2008 RETIRED 5/18) |
Chief Executive Officer (CEO) |
Vivoryon (Group) |
Germany |
| Glück, Tobias (Rentschler 202210– SVP Human Relations before Novartis Deutschland) |
Human Resources Manager |
Rentschler (Group) |
Germany |
| Gläser-Fischer, Kerstin (Thermo Fisher Scientific, D 200809) |
Sales Manager / Marketing Manager |
Thermo Fisher (Group) |
Germany |
| Glöckner, Frank Oliver (MPI Bremen + Jacobs Univ Bremen + Ribocon GmbH) |
Professor |
Max Planck Society for the Advancement of Science |
Germany |
| Glöggler, Klaus (DeklaTec GmbH 201110 Managing Director) |
Managing Director |
DeklaTec GmbH |
Germany |
| Glöggler, Sabine (Candor Bioscience 201310 Marketing + Communication) |
Sales Manager / Marketing Manager |
Candor Bioscience GmbH |
Germany |
| Gmuender, Marcel (Roche 201706 Global Head Diabetes Care) |
President/Director/Head Business Group/Unit/Division |
Roche (Group) |
Switzerland |
| Gnad-Vogt, Ulrike (CureVac 201710 CMO) |
Chief Medical Officer (CMO) |
CureVac (Group) |
Germany |
| Gockel, Peter (ChemCon GmbH 201209 Managing Director) |
Managing Director |
ChemCon GmbH |
Germany |
| Goddard, Colin (FoRx Therapeutics 202004– Executive Chairman former CEO of OSI Pharmaceuticals) |
Board member, executive |
FoRx Therapeutics AG |
Switzerland |
| Godde, Dirk (Digomed GmbH 201305 Managing Director) |
Managing Director |
Digomed: Medical IT – Solutions GmbH |
Germany |
| Godet, Franck (Wieland Capital 201811 Managing Partner before BNP Paribas + CSFB + DLJ + Paribas) |
Managing Partner (investment firm) |
Wieland Capital GmbH & Co. KG |
Germany |
| Godewerth, Thelse (Eppendorf 201801– VP Corp Human Resources + Organisational Development) |
n. a. |
Eppendorf (Group) |
Germany |
| Godl, Klaus (Kinaxo 200910 CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Evotec (Group) |
Germany |
| Godula, Michal (Thermo Fisher 201304 Marketing Manager Food Safety and Environmental Applications) |
Sales Manager / Marketing Manager |
Thermo Fisher (Group) |
United States (USA) |
| Goebel, Frank (BRAIN 201703–201812c CFO joined 201502 before Royal Bank of Scotland WANTS TO LEAVE 8/18) |
Chief Financial Officer (CFO) |
BRAIN Biotech (Group) |
Germany |
| Goebel, Werner (Universität Würzburg 200504) |
n. a. |
University of Würzburg |
Germany |
| Goedesky, George (Bruker 201009 Exec Director Marketing + BusDev MALDI Biotyper) |
Sales Manager / Marketing Manager |
Bruker (Group) |
United States (USA) |
| Goergen, Bernd (High-Tech Gründerfonds 2007– Senior-Investmentmanager before DZ Bank 2000–2007) |
Investment Manager |
High-Tech Gründerfonds (HTGF) (Group) |
Germany |
| Goetz, Wolfgang (Transcatheter Technologies 201105 CEO) |
Chief Executive Officer (CEO) |
Transcatheter Technologies GmbH |
Germany |
| Goff, Marcia (Thermo Fisher –201805 LEFT) |
n. a. |
Thermo Fisher (Group) |
United States (USA) |
| Gohlke, Rüdiger (GSG Mess- und Analysengeräte 200803 Managing Director) |
Managing Director |
GSG Mess- und Analysengeräte GmbH |
Germany |
| Gohm, Harald (Tirol (govt) 201105 Standortagentur Tirol Managing Director) |
Managing Director |
Tirol (govt region) |
Austria |
| Goig, André (Syngenta 201306 Regional Director EAME + Chairman of EuropaBio since 201306) |
Regional manager |
Syngenta (Group) |
Switzerland |
| Goker, Hakan (Merck (DE) 201509 Senior Investment Direcotor MS Ventures before Aescap Venture + Atlas Venture) |
Investment Manager |
Merck (DE) (Group) |
Germany |
| Gold, Ludwig (Miracor 201407 CEO) |
Chief Executive Officer (CEO) |
Miracor (Group) |
Austria |
| Goldenbaum, Stephan (Solis BioDyne 202109– CEO before Eppendorf + Qiagen) |
Chief Executive Officer (CEO) |
Solis BioDyne OÜ |
Estonia |
| Goldenstein, Lissa (Auxogyn 201210 CEO) |
Chief Executive Officer (CEO) |
Auxogyn Inc. |
United States (USA) |
| Goldman, Jonathan (Abzena 202201 CEO formerly Aptuit CEO) |
Chief Executive Officer (CEO) |
Abzena (Group) |
United Kingdom (GB) |
| Goldman, Michel (Innovative Medicines Initiative 201103 Executive Director) |
President/Director/Head Business Group/Unit/Division |
Innovative Medicines Initiative (IMI + IMI2) |
EU (European Union) |
| Goldschmidt, Colin (Sonic Healthcare 201701 CEO + Managing Director) |
Chief Executive Officer (CEO) |
Sonic Healthcare (Group) |
Australia |
| Goldsmith, George (Compass Pathways 202004 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Compass Pathways (Group) |
United Kingdom (GB) |
| Goldsmith, Neil (Sundew 202009 Chairman before Evolva –200910–201707 CEO STEPPED DOWN 7/17) |
Chief Executive Officer (CEO) |
Sundew ApS |
Denmark |
| Goletz, Steffen (Glycotope 201601– CSO before since 200809 Managing Director + Founder) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Glycotope (Group) |
Germany |
| Goll, Alexandra (TVM 200512) |
General Partner (venture partner) |
TVM (Group) |
Germany |
| Golla, Stephan (Univ of Western Sydney 201203) |
n. a. |
University of Western Sydney (UWS) |
Australia |
| Goller, Alexandra (MorphoSys 201803 Associate Director Corp Comm & IR) |
Public Relations Manager / Investor Relations Manager |
MorphoSys (Group) |
Germany |
| Golson, Russell (PreOmics 201712– CCO before Computomics + Biognosys + BioSilta + Febit + MWG Biotech) |
Chief Commercial Officer (CCO) |
Bruker (Group) |
Germany |
| Golumbeski, George (Celgene 201804 EVP + Executive Advisor for Innovation + proposed to MorphoSys Supervisory Board) |
President/Director/Head Business Group/Unit/Division |
Bristol-Myers Squibb (BMS) (Group) |
United States (USA) |
| Gombert, Till (Protectimmun 200808 Founder) |
Company Founder |
Protectimmun GmbH |
Germany |
| Gonçalves, Dulce (Auven Therapeutics 201409– Corporate Counsel at ADC Therapeutics before Novartis) |
General Counsel / Chief Legal Officer (CLO) |
ADC Therapeutics (Group) |
Switzerland |
| Gonciarz, Grzegorz (Resistell 202007 COO) |
Chief Operating Officer (COO) |
Resistell AG |
Switzerland |
| Gonin, Marc (TOFwerk 202205 CEO + Co-Founder) |
Chief Financial Officer (CFO) |
TOFwerk AG |
Switzerland |
| Gonthiez, Thierry (Resolution Spectra Systems 202007 General Manager + Co-Founder) |
General Manager (management) |
Merck (DE) (Group) |
France |
| Gooch, Daniel (Scius Communciations 202109 formerly Instinctif Partners 201509) |
Public Relations Manager / Investor Relations Manager |
Scius Communications (GB) |
United Kingdom (GB) |
| Goodwin, Elizabeth (Galapagos 201112 Director Investor Relations) |
Public Relations Manager / Investor Relations Manager |
Galapagos (Group) |
Belgium |
| Goorden, Bram (Sophia Genetics 202011– CCO + Head North America before Foundation Medicine + Prometheus Labs + Lilly) |
Chief Commercial Officer (CCO) |
Sophia Genetics (Group) |
United States (USA) |
| Gorbachev, Maxim (Russia (govt) 201501 Partner at RMI Partners) |
Partner (venture partner) |
Russia (govt) |
Russian Federation |
| Gordon, Carl L. (OrbiMed Advisors 201509 Partner) |
Partner (venture partner) |
OrbiMed (Group) |
United States (USA) |
| Gordon, Jenn (Global Health PR 201901) |
Public Relations Manager / Investor Relations Manager |
Global Health PR (US) |
United States (USA) |
| Gordon, Steven J. (Intelligent Bio-Systems 201206 CEO + founder) |
Chief Executive Officer (CEO) |
Qiagen (Group) |
United States (USA) |
| Goris, Ludwig (Capricorn Venture Partners 201808 Investment Manager) |
Investment Manager |
Capricorn Venture Partners (Group) |
Belgium |
| Gorman, Kevin (Neurocrine Biosciences 202005 CEO) |
Chief Executive Officer (CEO) |
Neurocrine Biosciences (Group) |
United States (USA) |
| Gorzka, Gabriele (Univ Kassel 201108 Head of OWWZ) |
President/Director/Head Business Group/Unit/Division |
University of Kassel |
Germany |
| Goschin, Jörg (Alstin GmbH 201108– Managing Director before Blackstone Group London + Cerberus Capital) |
Managing Director |
MASCHMEYER Group (family Maschmeyer) |
Germany |
| Gossé, Jörn (Körber 201905 CEO of Körber Medipak Systems) |
Chief Executive Officer (CEO) |
Körber (Group) |
Germany |
| Gotteland, Jean-Pierre (ObsEva 201701 CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
ObsEva (Group) |
Switzerland |
| Gottraux, Jean-Claude (Roche 201404 Head of Roche Professional Diagnostics) |
President/Director/Head Business Group/Unit/Division |
Roche (Group) |
Switzerland |
| Gottschalk, Gerhard |
n. a. |
Project »Genomforschung an Mikroorganismen zur Analyse und Nutzung der Biodiversität« (Kompetenznetz, Uni Göttingen) |
Germany |
| Gottschalk, Uwe (Lonza 201406– CTO of Lonza Pharma&Biotechbefore Sartorius Stedim Biotech + Bayer Heatlhcare) |
Chief Technology/Technical Officer (CTO) |
Lonza (Group) |
Switzerland |
| Gouliaev, Alex Haahr (Nuevolution 201205 CEO + Co-founder before NeuroSearch) |
Chief Executive Officer (CEO) |
Nuevolution (Group) |
Denmark |
| Goundis, Dimitri (MaxiVax 201602– CEO before Acrongenomics + Speedel + Medicines Co Inc + Roche) |
Chief Executive Officer (CEO) |
MaxiVax S.A. |
Switzerland |
| Goutopoulos, Andreas (Merck (DE) 202004 Senior Scientific Director at EMD Serono + CSO at Metabomed + EiR at M Ventures) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Merck (DE) (Group) |
United States (USA) |
| Graber, Armin (Biocrates 200502 Managing Director) |
Managing Director |
Biocrates (Group) |
Austria |
| Grabert, Sebastian (Euronext 201709 Director Germany Representative before HSCBC + Berenberg) |
Sales Manager / Marketing Manager |
Euronext (Group) |
Netherlands |
| Grabulovski, Dragan (Bellevue 202109– Venture Partner at Pureos Bioventures before Covagen CSO + co-founder) |
Partner (venture partner) |
Bellevue (Group) |
United Kingdom (GB) |
| Gradnik, Roberto (Merck Serono –200708– Head of Operations Europe) |
n. a. |
Merck (DE) (Group) |
Germany |
| Graewe, Thomas (Amedrix 201109 Managing Director) |
Managing Director |
Amedrix GmbH |
Germany |
| Graf von Stosch, Andreas (Bosch Graf von Stosch Jehle 200809) |
n. a. |
Bosch Graf von Stosch Jehle (Munich) |
Germany |
| Graf, Marcus (Geneart 199911– co-founder + 5/06 head Bus Unit gene synthesis) |
President/Director/Head Business Group/Unit/Division |
Thermo Fisher (Group) |
Germany |
| Graf, Peter (Bavaria (govt) 201902 Investment Manager at BayBG) |
Investment Manager |
Bavaria (govt region) |
Germany |
| Graham, John (Menarini 201504 Chief Executive of Menarini Asia-Pacific Pte Ltd) |
Chief Executive Officer (CEO) |
Menarini (Group) |
Singapore |
| Graham, Peter (ADC Therapeutics 202211– Chief Legal Officer before Halozyme Therapeutics + Delcath Systems) |
General Counsel / Chief Legal Officer (CLO) |
ADC Therapeutics (Group) |
Switzerland |
| Graimann, Bernhard (Otto Bock 201009) |
n. a. |
Ottobock (Otto Bock) (Group) |
Germany |
| Grainger, David (Medixci Ventures 201602– General Partner before Index Ventures 2012– + Funxional Therapeutics) |
General Partner (venture partner) |
Medicxi Ventures (formerly Index Ventures Life Sciences) |
United Kingdom (GB) |
| Gramatica, Ruggero (Therametrics –201309 CEO RESIGNED 9/13) |
Chief Executive Officer (CEO) |
Relief Therapeutics (Group) |
Switzerland |
| Grandidier, Laurent (Xeltis 201412 CEO) |
Chief Executive Officer (CEO) |
Xeltis (Group) |
Switzerland |
| Granese, Don (Sophia Genetics 202002 Media Relations Manager US) |
Public Relations Manager / Investor Relations Manager |
Sophia Genetics (Group) |
United States (USA) |
| Graney, Tom (Oxurion 202105– CEO joined as CFO 10/20 before Generation Bio + Vertex Pharma + Ironwood Pharma + JnJ) |
Chief Executive Officer (CEO) |
Oxurion (Group) |
Belgium |
| Granger, Chris (Immunotec 200508 Director of Sales) |
Sales Manager / Marketing Manager |
IMMUNOTEC Immunologisch-technische Produkt- und Beratungs GmbH |
Germany |
| Granier, Benoit (Unisensor (BE) 201805 CEO) |
Chief Executive Officer (CEO) |
Unisensor S.A. (BE) |
Belgium |
| Grant, Nick (AMETEK 201610 VP Material Analysis Division) |
President/Director/Head Business Group/Unit/Division |
AMETEK (Group) |
United States (USA) |
| Granzer, Ulrich |
Venture Partner |
Wellington Partners (Group) |
Germany |
| Grassauer, Andreas (Marinomed Biotechnologie GmbH 201307 CEO) |
Chief Executive Officer (CEO) |
Marinomed Biotech AG (VSE: MARI) |
Austria |
| Grassmann, Heike (Helmholtz 202210 Administrative Director at Max Delbrück Center) |
President/Director/Head of Research Organisation/Unit |
Helmholtz-Gemeinschaft (HGF) (Group) |
Germany |
| Grau, Daniel (Heptares 201111– President Corporate + Commercial Development before Cortia Corp + CombinatoRx) |
Business Development Manager / Strategy Manager |
Sosei (Group) |
United Kingdom (GB) |
| Grau, Michael (Kuros 202209 CFO before Proteros + Correvio + Ingenium + MorphoSys) |
Chief Financial Officer (CFO) |
Kuros (Group) |
Switzerland |
| Grau, Ulrich (Micromet 201106–2012 COO before Lux Biosciences CEO before Enzon 2002–2005 CSO before BASF/Knoll) |
Chief Operating Officer (COO) |
Amgen (Group) |
Germany |
| Grau, Volker (SMS Service für Massenspektrometrie GmbH 2008 Managing Director) |
Managing Director |
SMS Service für Massenspektrometrie GmbH |
Germany |
| Graupner, Stefan |
n. a. |
University of Bremen |
Germany |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo-2019.png){kind=logo}
1 2 3 ... 23 24 25 ... 81 82 83 
![Picture [iito] Männer Ballett 650x100px](/banner/iito-business-intelligence-20211013-650-100-summer-banner-series-maenner-ballett.jpg)
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
